Meiosis Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 05-07-2024
- Paid Up Capital ₹ 2.18 M
as on 05-07-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.63 Cr
as on 05-07-2024
- Satisfied Charges ₹ 1.17 Cr
as on 05-07-2024
- Revenue 74.82%
(FY 2023)
- Profit 11.05%
(FY 2023)
- Ebitda -15.86%
(FY 2023)
- Net Worth 7.89%
(FY 2023)
- Total Assets -17.14%
(FY 2023)
About Meiosis Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.18 M.
The company currently has active open charges totaling ₹1.63 Cr. The company has closed loans amounting to ₹1.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nilesh Kumbhar, Kishor Kumbhar, and Krishnarao Kumbhar serve as directors at the Company.
- CIN/LLPIN
U24100PN2012PTC144005
- Company No.
144005
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Meiosis Chemicals Private Limited offer?
Meiosis Chemicals Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Mud Chemicals.
Who are the key members and board of directors at Meiosis Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Kumbhar  | Director | 04-Jul-2016 | Current |
| Kishor Kumbhar | Director | 12-Jul-2012 | Current |
| Krishnarao Kumbhar | Director | 12-Jul-2012 | Current |
Financial Performance of Meiosis Chemicals.
Meiosis Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74.82% increase. The company also saw a substantial improvement in profitability, with a 11.05% increase in profit. The company's net worth moved up by a moderate rise of 7.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meiosis Chemicals?
In 2023, Meiosis Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 16 Nov 2023 | ₹1.63 Cr | Open |
State Bank Of India Creation Date: 18 Jul 2013 | ₹1.17 Cr | Satisfied |
How Many Employees Work at Meiosis Chemicals?
Meiosis Chemicals has a workforce of 6 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meiosis Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meiosis Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
